Table 3.
Effect sizes of non-pharmacologic interventions
| Study | Outcome measurement | Effect size |
|---|---|---|
| OT studies (Disability measures) | ||
| Gitlin 2001 | ADL dependence | −0.222 |
| IADL dependence | −0.437 | |
| Gitlin 2005 | Days receiving caregiver help | -- |
| Gitlin 2008 | Activity engagement | 0.61 |
| Gitlin 2003 | IADL functional | 0.048 |
| Gitlin 2010 | IADL dependence | 0.43 |
| Graff 2006 | AMPS process | 2.5 |
| Nobili 2004 | -- | |
| Exercise studies (Functional Impairment measures) | ||
| Hauer 2012 | 1RM | 0.18 |
| TGUG | 0.07 | |
| Walking speed | 0.15 | |
| Kwak 2008 | Muscle strength | 1.107 |
| Netz 2007 | TGUG | 0.426 |
| Schwenk 2010 | Motor (gait speed) + cognitive performance | 0.982 |
| Steinberg 2009 | YPAS | -- |
| Teri 2003 | SF-36 | 0.591 |
| SIP Mobility | 0.047 | |
| Other studies (Disability measures) | ||
| Burgener 1998 | Total intervention | -- |
| Callahan 2006 | ADL | 0.231 |
| Martin Cook 2005 | ILS | 2.014 |
| Nourhashemi 2010 | ADCS-ADL | 0.055 |
| Olazaran 2004 | FAQ | -- |
Notes: ADL, activities of daily living; IADL, instrumental activities of daily living; D-QOL, Dementia-Quality of Life; AMPS, Assessment of Motor and Process Skills; 1RM, 1RM, 1 rep max test; TGUG, Timed up and go test; YPAS, Yale Physical Activity Survey; SF-36, Short-form (36); SIP, Sickness Impact Profile; DEM-QOL, Dementia Quality of Life scale, ILS, Independent Living Scale; Alzheimer’s Disease Cooperative Study-Activities of Daily Living; FAQ, Functional Activities Questionnaire.